Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I2MA
|
|||
| Former ID |
DIB010265
|
|||
| Drug Name |
IO-21
|
|||
| Indication | Ulcer [ICD-11: CA02-CB40; ICD-10: K25-K27; ICD-9: 531-534] | Discontinued in Phase 2 | [1] | |
| Company |
Nissin Foods Holdings Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Streptococcus Diphtheria protein (Stre DIPP) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002135) | |||
| REF 2 | Interplay between Longitudinal and Transverse Contrasts in Fe3O4 Nanoplates with (111) Exposed Surfaces. ACS Nano. 2014 August 26; 8(8): 7976-7985. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.